{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:47:59Z","timestamp":1790268479853,"version":"4.1.0"},"reference-count":116,"publisher":"JLE","issue":"7","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.nephro.2015.10.001","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T03:31:02Z","timestamp":1445916662000},"page":"574-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["N\u00e9phropathie aux acides aristolochiques (\u00ab\u00a0n\u00e9phropathie aux herbes chinoises\u00a0\u00bb)"],"prefix":"10.1684","volume":"11","author":[{"given":"Jo\u00eblle","family":"Nortier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Pozdzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Roumeguere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Vanherweghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2015.10.001_bib0585","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","article-title":"Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs","volume":"341","author":"Vanherweghem","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib0590","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/acm.1998.4.1-9","article-title":"Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy)","volume":"4","author":"Vanherweghem","year":"1998","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.nephro.2015.10.001_bib0595","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0272-6386(12)80178-8","article-title":"Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs","volume":"24","author":"Depierreux","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0600","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(94)90964-4","article-title":"Identification of aristolochic acid in Chinese herbs","volume":"343","author":"Vanhaelen","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib0605","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0610","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ndt\/gfr291","article-title":"Aristolochic acid nephropathy: variation in presentation and prognosis","volume":"27","author":"Yang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0615","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM200310163491619","article-title":"Aristolochic acid, an herbal carcinogen, sold on the Web after FDA alert","volume":"349","author":"Gold","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.10.001_bib0620","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.nephro.2015.10.001_bib0625","first-page":"2025","article-title":"Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy","volume":"56","author":"Schmeiser","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nephro.2015.10.001_bib0630","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","article-title":"Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"342","author":"Nortier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2015.10.001_bib0635","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ndt\/18.2.426","article-title":"Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure","volume":"18","author":"Nortier","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0640","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0272-6386(99)70136-8","article-title":"Urothelial lesions in Chinese-herb nephropathy","volume":"33","author":"Cosyns","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0645","first-page":"118","article-title":"IARC monographs on the evaluation of carcinogenic risks to humans: some traditional herbal medicines, some mycotoxins, naphtalene and styrene","volume":"82","author":"World Health Organization","year":"2002","journal-title":"IARC Publ"},{"key":"10.1016\/j.nephro.2015.10.001_bib0650","author":"Lewis","year":"2000"},{"key":"10.1016\/j.nephro.2015.10.001_bib0655","series-title":"L\u2019herbier toxique. Codes secrets pour plantes utiles","author":"Bertrand","year":"2009"},{"key":"10.1016\/j.nephro.2015.10.001_bib0660","series-title":"Le grand livre des plantes magiques. Jardin de sorci\u00e8re","author":"La\u00efs","year":"2003"},{"key":"10.1016\/j.nephro.2015.10.001_bib0665","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jep.2009.05.028","article-title":"Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1\u00a0and 2\u2013a global assessment based on bibliographic sources","volume":"125","author":"Heinrich","year":"2009","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0670","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1383-5718(01)00171-1","article-title":"Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase\u2013(32)P-postlabeling analysis of DNA adduct formation","volume":"493","author":"Stiborova","year":"2001","journal-title":"Mutat Res"},{"key":"10.1016\/j.nephro.2015.10.001_bib0675","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/carcin\/18.5.1063","article-title":"32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy","volume":"18","author":"Bieler","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0680","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/tx00023a015","article-title":"N6-adenyl arylation of DNA by aristolochic acid II and a synthetic model for the putative proximate carcinogen","volume":"4","author":"Pfau","year":"1991","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0685","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0940-2993(99)80033-5","article-title":"Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy","volume":"51","author":"Stiborova","year":"1999","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0690","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/dmd.106.013979","article-title":"Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats","volume":"35","author":"Chan","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nephro.2015.10.001_bib0695","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jpba.2007.11.042","article-title":"Aristolochic acid induced changes in the metabolic profile of rat urine","volume":"46","author":"Chan","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.nephro.2015.10.001_bib0700","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3109\/00498258709044197","article-title":"Studies on the metabolism of aristolochic acids I and II","volume":"17","author":"Krumbiegel","year":"1987","journal-title":"Xenobiotica"},{"key":"10.1016\/j.nephro.2015.10.001_bib0705","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jasms.2006.11.010","article-title":"Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids","volume":"18","author":"Chan","year":"2007","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1016\/j.nephro.2015.10.001_bib0710","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mrfmmm.2008.08.012","article-title":"Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry","volume":"646","author":"Chan","year":"2008","journal-title":"Mutat Res"},{"key":"10.1016\/j.nephro.2015.10.001_bib0715","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/carcin\/13.10.1835","article-title":"Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I","volume":"13","author":"Fernando","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0720","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/carcin\/23.4.617","article-title":"Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy","volume":"23","author":"Stiborova","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0725","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00204-003-0438-y","article-title":"Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy","volume":"77","author":"Debelle","year":"2003","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0730","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2008.125","article-title":"Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid","volume":"73","author":"Stiborova","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0735","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/tx010059z","article-title":"Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1\u00a0and 1A2","volume":"14","author":"Stiborova","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0740","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/carcin\/bgg119","article-title":"Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase","volume":"24","author":"Stiborova","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0745","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ijc.20564","article-title":"Human hepatic and renal microsomes, cytochromes P450 1A1\/2, NADPH:cytochrome P450\u00a0reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer","volume":"113","author":"Stiborova","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nephro.2015.10.001_bib0750","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/ki.2008.103","article-title":"Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity","volume":"73","author":"Xiao","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0755","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.tox.2009.07.014","article-title":"Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy","volume":"264","author":"Bakhiya","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.nephro.2015.10.001_bib0760","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1254\/jphs.09339SC","article-title":"Interactions of human organic anion transporters with aristolochics acids","volume":"113","author":"Babu","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.nephro.2015.10.001_bib0765","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0272-6386(00)70343-X","article-title":"Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs","volume":"35","author":"Yang","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0770","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000046647","article-title":"Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications","volume":"21","author":"Chang","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0775","first-page":"198","article-title":"The characteristic pattern of aminoaciduria in patients with aristolochic acid-induced Fanconi syndrome: could iminoaciduria be the hallmark of this syndrome?","volume":"54","author":"Tanaka","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0780","first-page":"301","article-title":"Chinese herb nephropathy in Japan presents adult-onset Fanconi syndrome: could different components of aristolochic acids cause a different type of Chinese herb nephropathy?","volume":"53","author":"Tanaka","year":"2000","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0785","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ndt\/gfl556","article-title":"Possible mechanisms explaining the tendency towards interstitial fibrosis in aristolochic acid-induced acute tubular necrosis","volume":"22","author":"Yang","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0790","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1561-5413(07)60003-9","article-title":"Aristolochic acid nephropathy: the Hong Kong perspective","volume":"9","author":"Poon","year":"2007","journal-title":"Honk Kong J Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0795","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.phymed.2006.05.009","article-title":"Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia related species and the importance of the pharmaceutical name during botanical drug product development","volume":"14","author":"Wu","year":"2007","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nephro.2015.10.001_bib0800","article-title":"Scalpels come out in TCM debate","author":"Xinhua","year":"2007","journal-title":"Shangai Daily"},{"key":"10.1016\/j.nephro.2015.10.001_bib0805","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1749-8546-3-13","article-title":"Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of national health insurance data in Taiwan between 1997\u00a0and 2003","volume":"3","author":"Hsieh","year":"2008","journal-title":"Chin Med"},{"key":"10.1016\/j.nephro.2015.10.001_bib0810","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ndt\/8.8.684","article-title":"Chronic renal failure in India","volume":"8","author":"Mani","year":"1993","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0815","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(05)63243-6","article-title":"Aristolochia sp. and chronic interstitial nephropathies in Indians","volume":"349","author":"Vanherweghem","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib0820","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jep.2015.03.036","article-title":"Substitution between Aristolochia and Bryonia genus in North-Eastern Morocco: toxicological implications","volume":"166","author":"Yamani","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0825","series-title":"Clinical nephrotoxins. Renal injury from drugs and chemicals","first-page":"587","article-title":"Balkan endemic nephropathy","author":"Djukanovic","year":"2003"},{"key":"10.1016\/j.nephro.2015.10.001_bib0830","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/mnfr.200790020","article-title":"An overview on toxicity and carcinogenicity in animals and humans","volume":"51","author":"Pfohl-Leszkowicz","year":"2007","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.nephro.2015.10.001_bib0835","first-page":"273","article-title":"Etiology of endemic nephropathy","volume":"91","author":"Ivic","year":"1969","journal-title":"Lijec Vjesn"},{"key":"10.1016\/j.nephro.2015.10.001_bib0840","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/ki.1994.220","article-title":"Chinese herbs nephropathy: a clue to Balkan endemic nephropathy?","volume":"45","author":"Cosyns","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0845","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/mutage\/17.4.265","article-title":"Aristolochic acid as a probable human cancer hazard in herbal remedies: a review","volume":"17","author":"Arlt","year":"2002","journal-title":"Mutagenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0850","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/carcin\/22.1.133","article-title":"Sequence-specific detection of aristolochic acid-DNA adducts in the human p53\u00a0gene by terminal transferase-dependent PCR","volume":"22","author":"Arlt","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0855","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1053\/j.ajkd.2003.11.024","article-title":"DNA adducts and p53\u00a0mutations in a patient with aristolochic acid-associated nephropathy","volume":"43","author":"Lord","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0860","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1681\/ASN.2007050537","article-title":"Role of environmental toxins in endemic (Balkan) nephropathy","volume":"18","author":"Grollman","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0865","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ki.2011.371","article-title":"Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid","volume":"81","author":"Jelakovic","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0870","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ki.2011.428","article-title":"Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy","volume":"81","author":"De Broe","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0875","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/ndt\/gft384","article-title":"Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy","volume":"29","author":"Jelakovic","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0880","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/ki.1995.449","article-title":"Low molecular weight proteinuria in Chinese herbs nephropathy","volume":"48","author":"Kabanda","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0885","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ki.1997.35","article-title":"Proximal tubular injury in Chinese herbs nephropathy: monitoring by neutral endopeptidase enzymuria","volume":"51","author":"Nortier","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0890","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1523-1755.2001.00938.x","article-title":"Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells","volume":"60","author":"Lebeau","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0895","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/BF00295084","article-title":"Acute toxicity of aristolochic acid in rodents","volume":"59","author":"Mengs","year":"1987","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0900","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF01973700","article-title":"Renal toxicity of aristolochic acid in rats as an example of nephrotoxicity testing in routine toxicology","volume":"67","author":"Mengs","year":"1993","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0905","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1046\/j.1523-1755.2001.00731.x","article-title":"Chronic aristolochic acid toxicity in rabbits: a model of Chinese herbs nephropathy?","volume":"59","author":"Cosyns","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0910","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1681\/ASN.V132431","article-title":"Aristolochic acids induce chronic renal failure with interstitial fibrosis in salt-depleted rats","volume":"13","author":"Debelle","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0915","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/ndt\/gfi042","article-title":"Early proximal tubule injury in experimental aristolochic acid nephropathy: functional and histological studies","volume":"20","author":"Lebeau","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0920","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.ki.5002714","article-title":"Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation","volume":"73","author":"Pozdzik","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0925","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1093\/ndt\/gfn140","article-title":"Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy","volume":"23","author":"Pozdzik","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib0930","first-page":"F1006","article-title":"Mecanism of chronic aristolochic acid nephropathy: role of Smad3","volume":"298","author":"Zhou","year":"2010","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0935","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2559.2010.03509.x","article-title":"Aristolochic acid nephropathy revisited: a place for innate and adaptive immunity?","volume":"56","author":"Pozdzik","year":"2010","journal-title":"Histopathology"},{"key":"10.1016\/j.nephro.2015.10.001_bib0940","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1211\/0022357023051","article-title":"Acute nephrotoxicity of aristolochic acids in mice","volume":"56","author":"Sato","year":"2004","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0945","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1124\/dmd.107.014688","article-title":"Selective toxicity of aristolochic acids I and II","volume":"35","author":"Shibutani","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nephro.2015.10.001_bib0950","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.taap.2007.03.029","article-title":"Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid","volume":"222","author":"Qi","year":"2007","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0955","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.tiv.2011.01.016","article-title":"Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1\/2\u00a0activation in human cells","volume":"25","author":"Yu","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.nephro.2015.10.001_bib0960","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1523-1755.2005.00277.x","article-title":"Structure activity relationships of aristolochic acid analogues: toxicity in cultured renal epithelial cells","volume":"67","author":"Balachandran","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0965","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s10495-006-0289-0","article-title":"Effect of aristolochic acid on intracellular calcium concentration and its links with apoptosis in renal tubular cells","volume":"11","author":"Hsin","year":"2006","journal-title":"Apoptosis"},{"key":"10.1016\/j.nephro.2015.10.001_bib0970","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1681\/ASN.2008111133","article-title":"Activation of p53\u00a0promotes renal injury in acute aristolochic acid nephropathy","volume":"21","author":"Zhou","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib0975","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/jpet.111.180984","article-title":"Physiological and molecular characterization of aristolochic acid transport by the kidney","volume":"338","author":"Dickman","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.nephro.2015.10.001_bib0980","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ki.2012.264","article-title":"Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy","volume":"82","author":"Baudoux","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0985","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(06)69079-X","article-title":"Chinese herbal uropathy and nephropathy","volume":"368","author":"Laing","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib0990","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0140-6736(01)06576-X","article-title":"Urothelial malignant disease and Chinese herbal nephropathy","volume":"358","author":"Lord","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib0995","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.ajkd.2004.09.019","article-title":"Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy","volume":"45","author":"Lo","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib1000","series-title":"Monographs on the evaluation of carcinogenic risks to humans","first-page":"1","author":"IARC","year":"2011"},{"key":"10.1016\/j.nephro.2015.10.001_bib1005","series-title":"Dietary supplements: aristolochic acid","author":"US Food Drug Administration","year":"2001"},{"key":"10.1016\/j.nephro.2015.10.001_bib1010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0140-6736(94)92786-3","article-title":"Urothelial malignancy in nephropathy due to Chinese herbs","volume":"344","author":"Cosyns","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib1015","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0300-483X(02)00486-9","article-title":"Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)","volume":"181\u20132","author":"Nortier","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.nephro.2015.10.001_bib1020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/ndt\/18.2.426","article-title":"Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure","volume":"18","author":"Nortier","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib1025","first-page":"270","article-title":"Chinese herbs nephropathy and renal pelvic carcinoma","volume":"10","author":"Vanherweghem","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib1030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.11.015","article-title":"Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up","volume":"51","author":"Lemy","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib1035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.eururo.2011.03.027","article-title":"Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non-muscle-invasive bladder cancer","volume":"59","author":"Zlotta","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.nephro.2015.10.001_bib1040","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/carcin\/bgm082","article-title":"Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer","volume":"28","author":"Arlt","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib1045","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jnci\/djp467","article-title":"Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk","volume":"102","author":"Lai","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.nephro.2015.10.001_bib1050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ijc.20316","article-title":"Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer 11","volume":"111","author":"Arlt","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nephro.2015.10.001_bib1055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ijc.28681","article-title":"Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy up to 20\u00a0years after exposure","volume":"135","author":"Schmeiser","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nephro.2015.10.001_bib1060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/carcin\/21.2.235","article-title":"Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene 2","volume":"21","author":"Arlt","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.nephro.2015.10.001_bib1065","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/ijc.24006","article-title":"TP53\u00a0mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours","volume":"124","author":"Nedelko","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nephro.2015.10.001_bib1070","first-page":"141","article-title":"Chemical and molecular basis of the carcinogenicity of Aristolochia plants","volume":"12","author":"Schmeiser","year":"2009","journal-title":"Curr Opin Drug Discov Dev"},{"key":"10.1016\/j.nephro.2015.10.001_bib1075","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1073\/pnas.1119920109","article-title":"Aristolochic acid-associated urothelial cancer in Taiwan","volume":"109","author":"Chen","year":"2012","journal-title":"Proc Nat Acad Sci"},{"key":"10.1016\/j.nephro.2015.10.001_bib1080","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/ndt\/gfg083","article-title":"High prevalence of fenfluramine-related aortic regurgitation in women with end-stage renal disease secondary to Chinese herb nephropathy","volume":"18","author":"Unger","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib1085","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/S0140-6736(05)63683-5","article-title":"Association of valvular heart disease with Chinese-herb nephropathy","volume":"350","author":"Vanherweghem","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib1090","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/12.1.81","article-title":"Chinese herbs nephropathy presentation, natural history and fate after transplantation","volume":"12","author":"Reginster","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib1095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ndt\/17.3.408","article-title":"Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose","volume":"17","author":"Martinez","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib1100","first-page":"157","article-title":"The tragic paradigm of Chinese herbs nephropathy","volume":"10","author":"van Ypersele de","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2015.10.001_bib1105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0272-6386(12)80186-7","article-title":"Acute interstitial nephritis following use of tung shueh pills","volume":"24","author":"Diamond","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib1110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2169\/internalmedicine.40.296","article-title":"Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium?","volume":"40","author":"Tanaka","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.nephro.2015.10.001_bib1115","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00467-006-0017-6","article-title":"Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs","volume":"21","author":"Hong","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.nephro.2015.10.001_bib1120","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/0140-6736(93)93099-M","article-title":"Adverse effects from traditional Chinese medicine","volume":"341","author":"Jadoul","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2015.10.001_bib1125","first-page":"274","article-title":"Hydron\u00e9phrose bilat\u00e9rale cons\u00e9cutive \u00e0 la prise d\u2019herbes chinoises\u00a0: enjeu diagnostique et th\u00e9rapeutique","volume":"23","author":"Richter","year":"2002","journal-title":"Nephrologie"},{"key":"10.1016\/j.nephro.2015.10.001_bib1130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200326010-00004","article-title":"Aristolochic acid and \u201cChinese herbs nephropathy\u201d: a review of the evidence to date","volume":"26","author":"Cosyns","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/j.nephro.2015.10.001_bib1135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7326\/0003-4819-158-6-201303190-00006","article-title":"The epidemiology, diagnosis and management of aristolochic acid nephropathy: a narrative review","volume":"158","author":"G\u00f6kmen","year":"2013","journal-title":"Ann Int Med"},{"key":"10.1016\/j.nephro.2015.10.001_bib1140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0272-6386(96)90542-9","article-title":"Effects of steroids on the progression of renal failure in chronic interstitial renal fibrosis: a pilot study in Chinese herbs nephropathy","volume":"27","author":"Vanherweghem","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.nephro.2015.10.001_bib1145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MOU.0b013e32832eb2a3","article-title":"How to improve the effectiveness of transurethral resection in non muscle invasive bladder cancer?","volume":"19","author":"Cauberg","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.nephro.2015.10.001_bib1150","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2165\/00003495-200666040-00010","article-title":"Hexyl aminolevulinate in the detection of bladder cancer","volume":"66","author":"Frampton","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.nephro.2015.10.001_bib1155","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000083277","article-title":"Fluorescence cystoscopy in the management of bladder cancer: a help for the urologist","volume":"74","author":"Lichlinski","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.nephro.2015.10.001_bib0580","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/tri.12484","article-title":"BCG therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy","volume":"28","author":"Roumeguere","year":"2015","journal-title":"Transplant Int"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725515006355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725515006355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2015.10.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:21:36Z","timestamp":1741191696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725515006355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":116,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S1769725515006355"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2015.10.001","relation":{},"ISSN":["1769-7255"],"issn-type":[{"value":"1769-7255","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N\u00e9phropathie aux acides aristolochiques (\u00ab\u00a0n\u00e9phropathie aux herbes chinoises\u00a0\u00bb)","name":"articletitle","label":"Article Title"},{"value":"N\u00e9phrologie & Th\u00e9rapeutique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nephro.2015.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Association Soci\u00e9t\u00e9 de n\u00e9phrologie. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}